Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001144204-17-051545

Options or other derivatives

  • Chief Financial Officer acquired 145,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Foster Jonathan P. · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-10-03 Grant or award : show line 1 in the form Stock option (right to buy) +145,000 545,000 D
Loading xslF345X03/v476493_4.xml…